Becton, Dickinson and Company (BDXB) は上場企業です ヘルスケア セクターの Medical - Instruments & Supplies 業界で事業展開. 本社所在地は Franklin Lakes, NJ, アメリカ. 現CEOは Thomas E. Polen Jr..
BDXB を有する IPO日 2020-05-21, 77,000 名の正社員, に上場 NYSE, 時価総額 $13.69B.
Becton, Dickinson and Company is a global leader in medical technology, developing, manufacturing, and distributing a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry through three primary business segments: BD Medical, which provides IV catheters, infusion systems, syringes, diabetes care products, and medication management solutions; BD Life Sciences, which offers specimen collection, microbiology automation, molecular testing systems, and cell analysis instruments; and BD Interventional, which specializes in surgical products, grafts, and critical care devices. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton Dickinson operates worldwide to advance patient care and clinical outcomes across multiple healthcare settings.